Explore Business Standard
Healthcare
Fitness firm Fittr is moving towards providing a holistic preventive healthcare service, combining diagnostics with doctor consultations, to target non-communicable diseases, according to its founder and CEO Jitendra Chouksey. The firm has earmarked investment of up to Rs 15 crore to set up company-owned diagnostic laboratories in five metro cities, while also collaborating with partners to expand its lab network to 5,000 pin codes across India, Chouksey told PTI. "We are moving towards a preventive healthcare ecosystem, where we are combining diagnostics with doctor consultations, along with coaching and wearable monitoring, to address one of the biggest pain points in the country today, which is the growing number of NCD (non-communicable diseases) deaths, which are happening in the country," he said. Earlier, Fittr operated primarily as a fitness company, where it used to render nutrition and training services with the help of its coaches, he noted. Chouksey was responding to a
A 44-year-old Indian-origin man has died of suspected cardiac arrest after waiting for more than eight hours for treatment in a hospital's emergency room area, a media report has said. Prashant Sreekumar began experiencing severe chest pains while at work on December 22, Global News reported on Wednesday. A client drove him to the Grey Nuns Hospital in southeast Edmonton, where Prashant was checked in at triage and then took a seat in the waiting room. His father, Kumar Sreekumar, soon arrived. He told me, Papa, I cannot bear the pain,' Kumar said. Kumar said his son told him and hospital staff the pain was a 15 out of 10. They did an electrocardiogram (ECG) on him to check his heart's function, but the family said Prashant was told there was nothing of significance and to keep waiting. Staff also offered Prashant some Tylenol for his pain. He waited, and waited some more. Kumar said as time passed, nurses would check Prashant's blood pressure. It went up, up, and up. To me,
Max Healthcare Institute Ltd on Thursday said it will invest over Rs 1,000 crore to set up a 450-bed super speciality hospital in Pune. The facility, situated in Yerawada, Pune, will mark the company's foray into the city and is expected to be commissioned over the next 3 years, Max Healthcare Institute Ltd said in a statement. The hospital will be the company's fourth facility in Western India. The company said its investment involves staggered acquisition of a 100 per cent equity stake in Yerawada Properties Pvt Ltd (YPPL), Pune and further development of the hospital over the course of next three years. "This proposed hospital will bring advanced medical care closer to patients in the region. Our entry into Pune is a strategic milestone for Max Healthcare and aligns with our long-term vision of expanding our presence in key healthcare markets across the country," Max Healthcare Institute Ltd Chairman and Managing Director, Abhay Soi said. Stating that Pune is one of India's ...
As many as 300 products, including that of engineering goods, pharma, agri, and chemicals, hold huge potential for Indian exporters to push their shipments to Russia as the two countries target USD 100 billion trade by 2030, an official said. At present, India's exports of these goods to Russia stood at USD 1.7 billion, as against Russia's USD 37.4 billion in imports. "This stark disparity demonstrates the substantial complementary export space India can target," the official said, adding increasing exports will also help India bridge its trade deficit with Russia, which stood at USD 59 billion. These high-potential products have been selected by the commerce ministry by analysing complementary basket of products -- mapping India's supply visa-a-vis Russia's demand across key sectors, the official added. The most promising areas mirror India's rising global strengths are engineering goods, pharmaceuticals, chemicals and agriculture, all of which correspond to substantial unmet dema
India and the US have a "huge potential" for collaboration in healthcare across segments such as AI and technology, drug development and medical hardware, world-renowned cardiovascular and cardiothoracic surgeon Dr Naresh Trehan said. "We are now in a stage where I think the time has come... It's India's time. I'm gung-ho myself, I would say that anybody... looking at India should move, don't waste anymore time because the opportunities are huge," Trehan, Chairman and Managing Director of Medanta and a Padma Bhushan awardee, said during a conversation here last week. The event was hosted by the Consulate General of India in New York here last week titled 'Healthcare in a Developed India 2047'. The Consulate said that the key highlights of the event included a vision to make high quality healthcare universally accessible and affordable; India's rising corps of highly trained medical and allied-health professionals. Strong emphasis on pharma innovation and research; transformative ro
